Growth hormone treatment and risk of malignancy

Korean journal of pediatrics
Hyun-Wook ChaeHo-Seong Kim

Abstract

Growth hormone (GH) treatment has been increasingly widely used for children with GH deficiencies as the survival rate of pediatric patients with malignancies has increased. Both GH and insulin-like growth factor-I have mitogenic and antiapoptotic activity, prompting concern that GH treatment may be associated with tumor development. In this review, the authors examined the relationship between GH treatment and cancer risk in terms of de novo malignancy, recurrence, and secondary neoplasm. Although the results from numerous studies were not entirely consistent, this review of various clinical and epidemiological studies demonstrated that there is no clear evidence of a causal relationship between GH treatment and tumor development. Nonetheless, a small number of studies reported that childhood cancer survivors who receive GH treatment have a small increased risk of developing de novo cancer and secondary malignant neoplasm. Therefore, regular follow-ups and careful examination for development of cancer should be required in children who receive GH treatment. Continued surveillance for an extended period is essential for monitoring long-term safety.

References

Dec 1, 1989·International Journal of Radiation Oncology, Biology, Physics·M WeissG D'Angio
Mar 28, 1987·Lancet·P E ClaytonD A Price
Apr 1, 1985·American Journal of Diseases of Children·S A ArslanianT P Foley
Dec 15, 1993·JAMA : the Journal of the American Medical Association·J E FradkinL L Robison
Jul 1, 1997·The Journal of Pediatrics·D B AllenS L Blethen
Jun 17, 2000·Endocrine Reviews·H M KhandwalaK E Friend
Jan 3, 2001·The Journal of Clinical Endocrinology and Metabolism·A J SwerdlowS M Shalet
Jan 11, 2001·Transplantation·G TydénU Berg
Feb 13, 2001·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·P CohenR G Rosenfeld
Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R J PackerT Moshang
Apr 6, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E M NoordaUNKNOWN Dutch Late Effects Study Group
Apr 20, 2001·Journal of the National Cancer Institute·J P NegliaL L Robison
Nov 10, 2001·The Journal of Clinical Endocrinology and Metabolism·G FrajeseJ P Monson
Jun 18, 2002·The Lancet Oncology·Gregor Fürstenberger, Hans-Jörg Senn
Jun 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wing LeungChing-Hon Pui
Jan 10, 2003·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Otto MehlsGerhard Opelz
Nov 6, 2003·International Journal of Cancer. Journal International Du Cancer·Renato BasergaKrysztof Reiss
Mar 30, 2004·Pediatric Blood & Cancer·Valérie Bernier
May 18, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Amanda L Ogilvy-Stuart, Helena Gleeson
Sep 2, 2004·European Journal of Endocrinology·David Wyatt
Nov 13, 2004·Hormone Research·Charles A Sklar
Aug 17, 2005·Hormone Research·Michael B RankeEdward O Reiter
Jul 11, 2006·The Journal of Clinical Endocrinology and Metabolism·Berrin Ergun-LongmireCharles A Sklar
Feb 22, 2007·Journal of the National Cancer Institute·Tara O HendersonLisa Diller
Mar 6, 2007·Endocrinology and Metabolism Clinics of North America·Indraneel Banerjee, Peter E Clayton
Mar 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anna T MeadowsPeter D Inskip
Nov 13, 2009·The Journal of Clinical Endocrinology and Metabolism·J BellB Lippe
Jun 5, 2010·Endocrine Development·Jean-Claude Carel, Gary Butler
Nov 15, 2011·Indian Journal of Pediatrics·Robert M Blizzard
Jul 17, 2012·International Journal of Radiation Oncology, Biology, Physics·Tara O HendersonLisa Diller
Jun 19, 2013·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Hyun Wook ChaeDuk Hee Kim
Aug 13, 2013·European Journal of Endocrinology·Sandra Pekic, Vera Popovic

❮ Previous
Next ❯

Citations

Sep 26, 2015·Climacteric : the Journal of the International Menopause Society·M Hagner-DerengowskaJ Budzyński
Mar 1, 2018·Frontiers in Endocrinology·Farhad DehkhodaAndrew J Brooks
Nov 1, 2018·AACE Clinical Case Reports·Jennifer J IyengarJennifer Wyckoff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.